Buy & Sell Broadcom Inc (AVGO) – Broadcom Inc Price Today
Key Stats
- $1.87TMarket Cap
- TechnologySector
- -19.9%3M Drawdown
- $1.91TEnterprise Value
- 0.66%Dividend Yield
- 35% Buy | 65% SellTrading Activity
- 73 daysTypical Hold Time
Broadcom Inc (AVGO) is currently valued at a market capitalization of $1.87T, with an enterprise value of $1.91T. Over the past 52 weeks, Broadcom Inc has traded between a low of $244.63 and a high of $481.57, highlighting its annual price range. Over the past three months, Broadcom Inc has recorded a drawdown of -19.9%, reflecting recent price volatility. Broadcom Inc offers a dividend yield of 0.66%, with the most recent dividend of $0.65 paid on 23 Mar 26. On average, investors hold Broadcom Inc for approximately 73 days, indicating typical investor behavior on the platform.
About Broadcom Inc
Broadcom--the combined entity of Broadcom and Avago--boasts a highly diverse product portfolio across an array of end markets. Avago focused primarily on radio frequency filters and amplifiers used in high-end smartphones, such as the Apple iPhone and Samsung Galaxy devices, in addition to an assortment of solutions for wired infrastructure, enterprise storage, and industrial end markets. Legacy Broadcom targeted networking semiconductors, such as switch and physical layer chips, broadband products (such as television set-top box processors), and connectivity chips that handle standards such as Wi-Fi and Bluetooth. The company has acquired Brocade, CA Technologies, Symantec's enterprise security business, and has a pending deal to acquire VMware to bolster its offerings in software.
Most Recent News
ConocoPhillips director sells shares amid oil price drop and rising supply concerns
A director at ConocoPhillips sold 1,974 shares worth about $235,000 following a 2.2% drop in the company's stock price amid a broader oil market downturn. The decline in oil prices was driven by increasing global supply, with key indicators like Bren...
Global Initiative on Loneliness and Connection hosts forum to tackle social division and loneliness worldwide
The Global Initiative on Loneliness and Connection (GILC) convened the 2026 Global Connection Forum on June 17 to address the growing public health crisis of loneliness and social isolation, which contribute to serious health risks and societal divis...
Metastatic prostate cancer market to grow strongly through 2036 with new targeted therapies emerging.
The metastatic prostate cancer market is shifting from traditional hormone therapies to precision, biomarker-driven treatments, including novel PARP inhibitors and PSMA-targeted radioligand therapies. The market, valued at $11.5 billion in 2025 in ma...
